Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.3K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.3K
Ligand Binding Sites02:40

Ligand Binding Sites

15.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.9K
Ligand Binding Sites02:40

Ligand Binding Sites

9.1K
9.1K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

6.0K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
6.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.4K
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LRP4 is an entry receptor for multiple encephalitic alphaviruses.

Nature communications·2026
Same author

State of Research in Pediatric Hospital Medicine.

Hospital pediatrics·2026
Same author

CD164 is an endolysomal host factor for entry of Clade A New World Arenaviruses.

bioRxiv : the preprint server for biology·2026
Same author

Protective human antibodies against Powassan virus.

Journal of virology·2026
Same author

Optimally engineered HLA/peptide-specific CAR-T cells outperform TCR-T cells to eradicate solid tumors.

Science advances·2026
Same author

Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025

Related Experiment Video

Updated: Apr 15, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

15.0K

Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.

Julia T Warren1, Wei Zou1, Corinne E Decker2

  • 1Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.

Journal of Cellular Biochemistry
|April 14, 2015
PubMed
Summary

Researchers engineered Receptor Activator of NF-κB Ligand (RANKL) variants with higher affinity for its receptor RANK. These RANKL mutations enhance osteoclast formation, revealing that RANKL signaling is not optimized and offering insights for osteoporosis therapies.

Keywords:
BONEKINETICSOSTEOCLASTRANKRANKLRECEPTORSIGNAL TRANSDUCTIONTNF-SUPERFAMILY

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.7K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.2K

Related Experiment Videos

Last Updated: Apr 15, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

15.0K
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.7K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.2K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • The RANKL/RANK/OPG axis regulates osteoclast differentiation and bone resorption.
  • Imbalances in this axis are linked to bone loss diseases like osteoporosis.
  • Osteoprotegerin (OPG) inhibits osteoclastogenesis by acting as a decoy receptor for RANKL.

Purpose of the Study:

  • To identify Receptor Activator of NF-κB Ligand (RANKL) mutations that enhance binding to RANK while reducing OPG interaction.
  • To investigate the functional consequences of increased RANKL-RANK affinity on osteoclastogenesis.
  • To explore the potential for designing novel anti-resorptive therapies by manipulating the RANKL/RANK axis.

Main Methods:

  • Yeast surface display was used to screen libraries of mutated RANKL proteins.
  • Recombinant RANKL variants with altered OPG binding and RANK affinity were generated.
  • Osteoclast lineage cells were used to assess signaling and osteoclastogenic potential of RANKL variants.

Main Results:

  • Several RANKL variants with significantly higher affinity for RANK than wild-type were identified.
  • RANKL variants with increased RANK affinity demonstrated enhanced signaling and osteoclastogenic potential.
  • A biphasic relationship between RANKL/RANK affinity and osteoclastogenic capacity was observed, driven by kinetic off-rate.

Conclusions:

  • Gain-of-function RANKL mutations can enhance osteoclastogenesis.
  • The physiological RANKL/RANK interaction may not be optimized for maximal signaling, possibly for receptor specificity.
  • Insights into manipulating RANKL/RANK affinity can inform the development of new anti-resorptive therapies for bone loss conditions.